A King’s College London spin-out company focusing on cardiovascular monitoring has raised £3.2m from new and existing institutional investors and individuals.
LiDCO, a company co-founded in 1991 by Dr David Band, researches, develops, manufactures and sells medical devices primarily for critical-care and high-risk patients who require real-time cardiovascular monitoring while undergoing major surgery, intensive care or cardiology procedures.
The company’s products include the LiDCO System and the PulseCO System, which when used together provide a range of data concerning the performance of a patient’s heart and blood circulation.
The products have been extensively validated and demonstrated to reduce the hospital stay of high-risk surgery patients by 12 days – saving £4,800 per patient treated. Extrapolated to the whole of the UK this would equate to a saving of £500m per annum for the National Health Service.
The company is listed on the Alternative Investment Market in London.